Amalgamated Bank increased its position in shares of Chemours Company (The) (NYSE:CC) by 49.8% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 37,858 shares of the specialty chemicals company’s stock after acquiring an additional 12,593 shares during the period. Amalgamated Bank’s holdings in Chemours Company (The) were worth $1,436,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently bought and sold shares of CC. BlackRock Inc. boosted its position in Chemours Company (The) by 48,297.2% in the first quarter. BlackRock Inc. now owns 19,160,930 shares of the specialty chemicals company’s stock valued at $737,696,000 after buying an additional 19,121,339 shares in the last quarter. Vanguard Group Inc. boosted its position in Chemours Company (The) by 1.2% in the first quarter. Vanguard Group Inc. now owns 18,773,273 shares of the specialty chemicals company’s stock valued at $722,771,000 after buying an additional 215,900 shares in the last quarter. FMR LLC boosted its position in Chemours Company (The) by 36.6% in the first quarter. FMR LLC now owns 14,925,373 shares of the specialty chemicals company’s stock valued at $574,627,000 after buying an additional 3,998,914 shares in the last quarter. State Street Corp boosted its position in Chemours Company (The) by 35.1% in the first quarter. State Street Corp now owns 5,791,792 shares of the specialty chemicals company’s stock valued at $222,987,000 after buying an additional 1,504,657 shares in the last quarter. Finally, Renaissance Technologies LLC boosted its position in Chemours Company (The) by 135.9% in the first quarter. Renaissance Technologies LLC now owns 3,031,400 shares of the specialty chemicals company’s stock valued at $116,709,000 after buying an additional 1,746,100 shares in the last quarter. Institutional investors and hedge funds own 72.90% of the company’s stock.

In other news, insider E Bryan Snell sold 13,000 shares of the firm’s stock in a transaction dated Tuesday, September 5th. The shares were sold at an average price of $49.35, for a total value of $641,550.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, VP Amy Trojanowski sold 2,500 shares of the firm’s stock in a transaction dated Friday, August 11th. The stock was sold at an average price of $46.03, for a total transaction of $115,075.00. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 38,837 shares of company stock valued at $1,865,603. Corporate insiders own 1.14% of the company’s stock.

Chemours Company (NYSE:CC) opened at 51.95 on Friday. The company has a market cap of $9.60 billion, a P/E ratio of 34.00 and a beta of 3.64. Chemours Company has a 52 week low of $14.12 and a 52 week high of $52.09. The company’s 50-day moving average is $50.42 and its 200-day moving average is $50.42.

Chemours Company (The) (NYSE:CC) last announced its quarterly earnings results on Wednesday, August 2nd. The specialty chemicals company reported $0.87 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.85 by $0.02. Chemours Company (The) had a net margin of 4.96% and a return on equity of 122.97%. The business had revenue of $1.59 billion during the quarter, compared to analysts’ expectations of $1.49 billion. During the same quarter in the prior year, the company posted $0.27 EPS. The firm’s revenue for the quarter was up 14.8% compared to the same quarter last year. On average, analysts anticipate that Chemours Company will post $3.51 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which was paid on Friday, September 15th. Stockholders of record on Thursday, August 17th were given a $0.03 dividend. The ex-dividend date was Tuesday, August 15th. This represents a $0.12 annualized dividend and a dividend yield of 0.23%. Chemours Company (The)’s dividend payout ratio is 8.11%.

ILLEGAL ACTIVITY WARNING: This report was first reported by Daily Political and is the sole property of of Daily Political. If you are reading this report on another website, it was illegally copied and reposted in violation of US & international trademark and copyright laws. The original version of this report can be accessed at https://www.dailypolitical.com/2017/09/22/amalgamated-bank-has-1-44-million-position-in-chemours-company-the-cc.html.

A number of equities analysts have recently commented on CC shares. ValuEngine upgraded shares of Chemours Company (The) from a “hold” rating to a “buy” rating in a report on Friday, June 2nd. Jefferies Group LLC reiterated a “buy” rating and set a $48.00 price target on shares of Chemours Company (The) in a report on Friday, June 16th. Citigroup Inc. upgraded shares of Chemours Company (The) from a “neutral” rating to a “buy” rating and lifted their price target for the stock from $43.00 to $45.00 in a report on Wednesday, July 5th. BidaskClub upgraded shares of Chemours Company (The) from a “hold” rating to a “buy” rating in a report on Wednesday, July 12th. Finally, Argus reiterated a “buy” rating and set a $55.00 price target (up previously from $50.00) on shares of Chemours Company (The) in a report on Thursday, August 10th. Two analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $51.50.

Chemours Company (The) Company Profile

The Chemours Company is a provider of performance chemicals. The Company operates through three segments: Titanium Technologies, Fluoroproducts and Chemical Solutions. The Titanium Technologies segment is a producer of titanium dioxide (TiO2). The Fluoroproducts segment is a provider of fluoroproducts, including refrigerants and industrial fluoropolymer resins.

Want to see what other hedge funds are holding CC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemours Company (The) (NYSE:CC).

Institutional Ownership by Quarter for Chemours Company (The) (NYSE:CC)

Receive News & Ratings for Chemours Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.